Ergawealth Advisors’s AbbVie ABBV Stock Holding History

Ergawealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.29M	Hold	5,116	–	–	0.5%	22
2026 Q1	$1.11M	Buy	5,116 +102	+2%	+$22.6K	0.49%	23
2025 Q4	$1.15M	Hold	5,014	–	–	0.53%	20
2025 Q3	$1.16M	Buy	5,014 +52	+1%	+$10.6K	0.54%	25
2025 Q2	$921K	Buy	4,962 +106	+2%	+$19.7K	0.41%	30
2025 Q1	$1.02M	Sell	4,856 -100	-2%	-$19.4K	0.5%	26
2024 Q4	$881K	Hold	4,956	–	–	0.44%	26
2024 Q3	$979K	Sell	4,956 -36	-0.7%	-$6.72K	0.49%	25
2024 Q2	$856K	Sell	4,992 -1,954	-28%	-$324K	0.47%	27
2024 Q1	$1.26M	Buy	6,946 +2,091	+43%	+$360K	0.69%	19
2023 Q4	$752K	Hold	4,855	–	–	0.46%	22
2023 Q3	$724K	Hold	4,855	–	–	0.5%	19
2023 Q2	$654K	Buy	4,855 +1	+0%	+$147	0.45%	19
2023 Q1	$774K	Hold	4,854	–	–	0.63%	20
2022 Q4	$784K	Buy	+4,854	New	+$744K	0.71%	20

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Ergawealth Advisors's ABBV Position: Q2 2026 in Review

Ergawealth Advisors held its AbbVie (ABBV) position steady in Q2 2026 at 5,116 shares worth $1.29M. The position accounts for 0.5% of the portfolio, ranked #22.

Ergawealth Advisors first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Ergawealth Advisors held 5,116 shares of AbbVie worth $1.29M as of Q2 2026.
Ergawealth Advisors left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.5% of Ergawealth Advisors's portfolio in Q2 2026, its #22 holding.
Ergawealth Advisors first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Ergawealth Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.